Shionogi & Co., Ltd. (SGIOF)

Market Cap	13.58B
Revenue (ttm)	3.05B
Net Income (ttm)	1.24B
Shares Out	n/a
EPS (ttm)	1.46
PE Ratio	10.94
Forward PE	n/a
Dividend	0.44 (3.10%)
Ex-Dividend Date	Sep 29, 2025

Volume	28,300
Average Volume	7,844
Open	14.25
Previous Close	15.54
Day's Range	14.25 - 14.25
52-Week Range	12.21 - 19.00
Beta	0.13
RSI	42.12
Earnings Date	Oct 27, 2025

About Shionogi &

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1878
• Employees: 4,955
• Stock Exchange: OTCMKTS
• Ticker Symbol: SGIOF

Financial Performance

In 2024, Shionogi &'s revenue was 438.27 billion, an increase of 0.73% compared to the previous year's 435.08 billion. Earnings were 170.44 billion, an increase of 5.19%.

Financial numbers in JPY